Medica RCP |Litak Injectable | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Litak Injectable

Contraindicated
Congenital malformations

Contraindicated

Litak Injectable :
Type	Medicine Authorised
Originator	B
Agent	Mediterranean Pharmaceutical Company
Distributor	Mediterranean Pharmaceutical Company
Laboratory	Lipomed
Responsible Party	Lipomed AG
Origin	Switzerland
Manufacturer	Haupt Pharma Wolfratshausen GmbH
Origin	Germany
ATC	L01BB04

Litak Injectable :

Injectable

Intravenous

Subcutaneous

Litak Injectable :

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01B Antimetabolites

L01BB Purine analogues

L01BB04 Cladribine

Litak Injectable :

Cladribine : 2mg/ml

Litak Injectable :

Chronic lymphocytic leukemia 0.1mg/kg/day

Hairy cell leukemia 0.14mg/kg/day

Non-Hodgkin’s lymphoma 0.1mg/kg/day

Waldenström’s macroglobulinemia 0.1mg/kg/day

Litak Injectable :

Hydrochloric acid (E507)

Sodium chloride

Sodium hydroxide (E524)

Water for injections

* Excipient with known effect

Hazard Level
◼ Major
◼ Moderate
◼ Minor
◼ Safe

Litak Injectable :

Revision Date : 27/03/2009

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Alopecia	Not known
Amyloidosis	Very rare
Anaemia	Very Common
Anxiety	Common
Arthralgia (Pain joint) (Joint ache)	Common
Arthritis	Common
Asthenia	Very Common
Ataxia	Uncommon
Atrial fibrillation	Rare
Blepharitis	Very rare
Blood bilirubin increased	Common
Bone marrow failure	Very Common
Bone pain	Common
Breath sounds abnormal	Very Common
Cachexia	Uncommon
Cardiac failure	Rare
Cardiac murmur	Common
Cerebrovascular accident	Rare
Chills	Very Common
Cholecystitis	Very rare
Confusional state	Uncommon
Conjunctivitis	Uncommon
Constipation	Very Common
Cough	Very Common
Decreased appetite	Very Common
Depression	Very rare
Diarrhoea (Diarrhea)	Very Common
Dizziness	Very Common
Dysphagia	Rare
Dyspnoea (dyspnea)	Common
Eosinophilia	Rare
Epilepsy	Very rare
Epistaxis (Nasal bleeding)	Common
Erythema	Common
Fatigue	Very Common
Flatulence	Common
Gastrointestinal pain	Common
Graft versus host disease	Rare
Haemolytic anemia	Uncommon
Haemorrhage	Common
Headache	Very Common
Hepatic failure (Hepatic insufficiency) (Liver failure)	Rare
Hyperhidrosis	Very Common
Hypotension	Common
Ileus	Rare
Immunosuppression	Very Common
Infection	Very Common
Injection site reaction	Very Common
Insomnia	Common
Lethargy	Uncommon
Lyell Syndrome (Toxic epidermal necrolysis)	Rare
Lymphopenia	Very Common
Malaise	Common
Mucosal inflammation	Common
Myalgia	Common
Myocardial ischaemia	Common
Nausea	Very Common
Neutropenia	Very Common
Oedema	Common
Pain	Common
Pain of skin	Common
Pancytopenia	Very Common
Paraesthesia (paresthesia)	Uncommon
Petechiae	Common
Pharyngitis	Uncommon
Phlebitis	Uncommon
Pneumonia	Very Common
Polyneuropathy	Uncommon
Pruritus	Common
Pulmonary embolism	Very rare
Purpura	Very Common
Pyrexia	Very Common
Renal failure	Rare
Second primary malignancy	Common
Sepsis (Systemic infection) (Sepsis state)	Very Common
Skin rash	Very Common
Somnolence	Uncommon
Speech disorder	Rare
Stevens-Johnson syndrome	Rare
Tachycardia	Common
Thrombocytopenia (Thrombopenia)	Very Common
Transaminases increased	Common
Tumour lysis syndrome	Rare
Urticaria	Common
Vomiting	Very Common

Litak Injectable :

Abu Dhabi

Belgium

Cyprus

Czech Republic

Denmark

Finland

France

Germany

Italy

Jordan

Lebanon

Norway

Portugal

Spain

Switzerland

The Netherlands

Tunisia

UAE

Form	Solution for injection
Packaging	Bottle (Glass)
Package Size	5x5ml
Strength	2mg/ml
Public Price	1968714 L.L.
Stratum	E2
NSSF	✔
Quarantine	✘
Reg. Number	96205/11
Submission date	01/01/2011
Registration Year	2012

Medicine Authorised

Cerubidine

Mersaco

Sanofi

TAU

Cerubidine²

Pharmamed

Sanofi

TAU

Cladribine 10mg

Pharmamed

Unknown

Medicine Authorised

Doxo-Cell 50mg

Drugstore 3U

Cell Pharm GmbH

TAU

Doxorubicin Hospira 10mg

Pharmamed

Hospira

TAU

Doxorubicin Hospira 50mg

Pharmamed

Hospira

Medicine Authorised

Doxorubicina Tedec 50mg²

Mediterranean Pharmaceutical Company

Tedec-Meiji

Medicine Authorised

Doxorubicine Ebewe 10mg

Khalil Fattal & Fils

Ebewe

Medicine Authorised

Doxorubicine Ebewe 50mg

Khalil Fattal & Fils

Ebewe

Medicine Authorised

Doxotil 10mg

Nobel Pharm Plus

Genepharm

Medicine Authorised

Doxotil 50mg

Nobel Pharm Plus

Genepharm

Medicine Authorised

Endoxan Injectable 500mg

Abela Freres

Baxter

Medicine Authorised

Epirubicine Ebewe 50mg

Khalil Fattal & Fils

Ebewe

Medicine Authorised

Epirubicine Mylan 10mg

Benta Trading Co

Mylan

Medicine Authorised

Epirubicine Mylan 50mg

Benta Trading Co

Mylan

Medicine Authorised

Fludarabine Ebewe

Khalil Fattal & Fils

Ebewe

Medicine Authorised

Fludarabine Neapolis

MedisPharm

Neapolis Pharma

TAU

Fludarabine Sagent

Medi Drug International

Sagent

TAU

Leustatin

Mersaco

Janssen

Medicine Authorised

Methotrexate Ebewe Injectable 500mg

Khalil Fattal & Fils

Ebewe